Lars Jønson and colleagues perform a next-generation sequencing analysis to evaluate the frequency of pathogenic RAD51C mutations identified in Danish breast and/or ovarian cancer families. They show that pathogenic RAD51C mutations were identified in 0.5 % of Danish families with increased risk of hereditary breast and/or ovarian cancer and suggest that RAD51C should be included in gene panel testing of individuals with high risk of breast and ovarian cancer.
Jønson, Lars et al. Breast Cancer Research and Treatment.
"We are very grateful for the work you do with Alamut and continuing to improve it. We use it on daily basis to help us interpret variants for clinical tests including our technicians, analysts, genetic counselors and lab directors. Alamut has the comprehensive information available for interpreting variants and great documentation. I’ve recommended Alamut to many customers who ask me about the tools that I use. Many thanks to you for making this possible."
Cincinnati Children's Hospital Medical Center